# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HYTN Innovations Inc. completes the acquisition of Prism Scientific Labs, enhancing its psychedelic compound manufacturing capa...
HYTN Innovations Inc. (CSE:HYTN) has successfully initiated cultivation of psilocybin mushrooms under its Dealer’s License gran...
HYTN Cannabis Inc., a wholly owned subsidiary of HYTN Innovations Inc. (CSE:HYTN) has entered into a sales, distribution and ma...
HYTN Cannabis Inc., a wholly owned subsidiary of HYTN Innovations Inc. (CSE:HYTN), has been awarded a Controlled Drugs and Subs...
HYTN Cannabis Inc. a wholly owned subsidiary of HYTN Innovations Inc.’s (CSE:HYTN), has entered into a manufacturing agreement ...
HYTN Cannabis Inc. wholly owned subsidiary of HYTN Innovations Inc., (CSE:HYTN) has developed and listed for sale its all-new N...
HYTN Cannabis Inc., wholly owned subsidiary of HYTN Innovations Inc. (CSE:HYTN) has been awarded a license by Health Canada all...
HYTN Innovations Inc. (CSE:HYTN) has successfully sold cannabis flower to serve the Australian medical cannabis market under th...
HYTN Innovations Inc. (CSE:HYTN) announced that it has begun accepting orders directly from Provincial buyers.